Company insight
Self-sampling veil for HPV/STD easy detection
Since cervical cancer is one of the most common forms of cancers in women worldwide, V-Veil-Up Production meets the WHO request for early detection, and has launched a self-sampling vaginal veil, created especially for HPV/papillomavirus and STDs detection.
C
ervical cancer is the second most common cancer in women worldwide, claiming between 250,000 and 300,000 lives each year. With so many cases of cervical cancer, the WHO is pushing harder on the diagnosis of human papillomavirus (HPV) and states that screening and treatment to prevent cervical cancer is still a global priority. There is interest in early detection of HPV because the earlier the treatment is performed, the more effective it is, but a major challenge remains: getting women to take the test. During gynaecological examinations, some women feel embarrassed, for various reasons, including cultural or religious values; others may experience physical discomfort or pain, while many women just don’t have enough time to make a doctor visit a priority, since their life agenda is pretty loaded. In this context, V-Veil-UP Production launched V-Veil UP2, a self-sampling veil for the detection of HPV and STDs. The product is simple and safe, respects the privacy of all women while also offers unequalled efficiency: it doubles the detection capacity of genomes, compared with conventional methods – according to a study conducted by Georges Pompidou Hospital in Paris, while the concept has been tested, validated and approved by the hospital’s professor, Laurent Belec.
Simple but efficient Inserted into the vaginal cavity, with the help of an applicator, the veil collector V-Veil UP2 is able to collect secretions, various fluids and substances found in the vagina and on the cervix. The secretions and DNA attach very easily to it; the woman simply has to wait for two minutes before removing the veil and inserting it into a transport tube. It will then be sent to a laboratory for PCR-Type molecular analysis. It can detect possible high-risk
Comparison of effectiveness between two methods.
and low-risk genomes, thus allowing for a rapid medical intervention and treatment. The V-Veil UP2 Collector was first tested on 256 women in Chad (while more than 98% of deaths due to cervical cancer occur in countries with low economic resources, 90% are located in sub-Saharan Africa) in order to compare the classic method – where the sampling is carried out by the gynaecologist – and self-sampling system with V-Veil UP2 Vaginal Veil Collector. The study results speak for themselves: ■ ■
97.1% acceptance rate
Nearly double detection capability of high-risk oncogenic papillomaviruses (HPV-HR) by multiplex real-time PCR, compared to standard swab sampling performed by a gynaecologist/nurse
In 2020, V-Veil-Up Production started manufacturing the Veil Collector V-Veil UP2, and the company already has a worldwide agreement with a PCR machine manufacturer to supply this medical device. The company offers multiple kit solutions, making sure its product is suitable for all national cervical cancer detection campaigns. Hence, its kit is: ■
very practical for NGOs that organise HPV screening campaigns
■ ■ Medical Device Developments /
www.nsmedicaldevices.com
an excellent solution for Muslim communities, since the sample can be taken by the woman alone or accompanied (by a midwife, for example) the only self-testing system with
scientific studies that show such good results, with or without a doctor.
The self-sampling veil collector proves to be an excellent solution for laboratories, as well, since the kit can be used with 15ml and 12ml tubes, directly with preanalytical robots, if the UP2 retrofitter is used. The retrofitter creates free empty space, in which the pipette of the robot can be easily introduced. Along with that, the V-Veil UP2 Collector offers other advantages: ■ ■ ■ ■ ■
faster processing safer
no contamination economic
ready for extraction
The origin of this discovery Bernard Chaffringeon is a French inventor, holding more than 150 patents, and a company director. He founded V-Veil-Up Production in 2019. He is the originator of patents for the V-Veil-UP2 self-sampling veil and industrial production machines. The project is a logical continuation of his previous work: his companies have been working on vaginal veils for more than eight years. His first patents, related to this kind of product, concerned a veil that allows the diffusion of medication into the vaginal cavity during the day, while suppressing any discharges. ●
https://hpv-veil.com 49
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136
